CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 206 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $751,775 | +252.9% | 37,015 | +345.5% | 0.00% | – |
| Q3 2022 | $213,000 | -58.2% | 8,309 | -67.9% | 0.00% | – |
| Q3 2021 | $510,000 | +0.6% | 25,899 | -14.2% | 0.00% | – |
| Q2 2020 | $507,000 | -58.3% | 30,170 | -70.5% | 0.00% | – |
| Q1 2020 | $1,216,000 | -49.7% | 102,209 | -48.8% | 0.00% | -100.0% |
| Q4 2019 | $2,416,000 | +358.4% | 199,628 | +344.3% | 0.00% | – |
| Q1 2019 | $527,000 | -1.7% | 44,926 | +31.7% | 0.00% | – |
| Q2 2018 | $536,000 | -80.7% | 34,125 | -79.8% | 0.00% | -100.0% |
| Q1 2018 | $2,781,000 | -57.1% | 169,050 | -52.9% | 0.00% | 0.0% |
| Q4 2017 | $6,486,000 | -7.5% | 359,145 | -1.2% | 0.00% | -50.0% |
| Q3 2017 | $7,013,000 | +126.9% | 363,363 | +38.7% | 0.00% | +100.0% |
| Q2 2017 | $3,091,000 | +131.4% | 261,933 | +114.8% | 0.00% | – |
| Q1 2017 | $1,336,000 | +161.4% | 121,948 | +73.3% | 0.00% | – |
| Q4 2016 | $511,000 | – | 70,351 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,951,077 | $178,226,000 | 9.95% |
| Parallel Advisors, LLC | 3,769,455 | $96,649,000 | 4.45% |
| Novo Holdings A/S | 3,327,768 | $85,324,000 | 4.07% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $911,000 | 2.72% |
| Quantedge Capital Pte Ltd | 243,712 | $6,249,000 | 1.93% |
| S&T BANK/PA | 349,456 | $8,960,000 | 1.73% |
| Birchview Capital, LP | 50,000 | $1,282,000 | 0.90% |
| Bridge City Capital, LLC | 61,254 | $1,571,000 | 0.86% |
| FAS Wealth Partners, Inc. | 299,576 | $7,681,000 | 0.85% |
| AJ WEALTH STRATEGIES, LLC | 509,934 | $13,075,000 | 0.76% |